Cardiology Poc Diagnostics Market Top Players, Segments & Regional Trends By 2034

Straits Research released its highly anticipated report, “Global Cardiology PoC Diagnostics Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 2.05 billion in 2025 and is anticipated to grow to USD 3.36 billion by 2034, growing at a CAGR of 5.68% from 2026-2034.

Market Dynamics

The global cardiology point-of-care (PoC) diagnostics market is driven by the growing burden of cardiovascular diseases, the ageing population, and increasing demand for rapid, accurate, and bedside diagnostic solutions. Advancements in high-sensitivity cardiac biomarker assays, including troponin and BNP, along with the integration of portable and connected PoC platforms, are enhancing clinical decision-making and enabling faster treatment initiation. However, the market faces restraints such as stringent regulatory approvals, variability in reimbursement structures, and limited accessibility in resource-constrained healthcare settings due to a shortage of trained personnel. Despite these challenges, emerging markets and the expansion of decentralized and home-based care models present lucrative opportunities, as innovations in AI-enabled PoC devices and cloud-integrated data management are transforming cardiac diagnostics toward more patient-centric and cost-effective care delivery.

Market Highlights

• Based on Product, the cholesterol/lipid profile test dominated the market in 2025 with a revenue share of 39.42%.
• Based on Technology, the lateral flow test (LFT) dominated the market with a revenue share of 47.25%.
• Based on End User, diagnostic laboratories dominated the market in 2025, with a revenue share of 42.34%.
• Regional Insights: North America dominated the market with more than 35.47% of market share in 2025.